UFP Technologies reported record financial results for the second quarter ended June 30, 2026. Net sales increased 15.1% to $174.0 million from $151.2 million in the prior year period, while net income rose 21.4% to $20.9 million from $17.2 million. GAAP diluted earnings per share reached $2.68 compared to $2.21 in Q2 2025, and adjusted diluted EPS was $2.92 versus $2.50. Gross margin expanded to 29.3% from 28.8%, and operating income grew 15.5% to $28.1 million. For the first half of 2026, net sales totaled $328.2 million with net income of $38.3 million. The company operates in the medical device contract development and manufacturing industry.

UFP Technologies, Inc. announced several leadership changes and compensation approvals on June 4, 2026. Ryan Stafford was appointed General Counsel, Senior Vice President of Human Resources, and Secretary, effective immediately, with a base salary of $400,000 and an annual equity award valued at $650,000. Mitchell C. Rock was appointed Chief Executive Officer and joined the Board of Directors following a board size increase from seven to eight members. Additionally, the Compensation Committee approved a $1 million stock unit award grant for Ronald J. Lataille, Senior Vice President and CFO. UFP Technologies is a manufacturer of specialized high-performance components.

UFP Technologies, Inc. has filed an 8-K to provide updated presentation materials concerning its business for use in investor meetings and presentations. The filing includes an updated business presentation as Exhibit 99.1.